array(2) { ["lab"]=> string(4) "1146" ["publication"]=> string(4) "9531" } Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis - 胃癌基础与临床转化研究实验室 | LabXing

Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis

2016
期刊 Journal of Controlled Release
下载全文